Ετικέτες

Πέμπτη 14 Ιουνίου 2018

ERBB Mutations and Clinical Outcomes Among Patients With Lung Squamous Cell Carcinoma

This secondary analysis of tumor specimens collected for the LUX-Lung 8 randomized clinical trial assesses whether ERBB gene mutations of family members were associated with outcomes among patients with lung squamous cell carcinoma randomized to treatment with afatinib or erlotinib.

https://ift.tt/2y7b8FA

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου